Search Results - "Csernok, E"

Refine Results
  1. 1

    Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis by Conticini, E, Hellmich, B, Frediani, B, Csernok, E, Löffler, C

    Published in Scandinavian journal of rheumatology (04-05-2023)
    “…There is a strong unmet need for biomarkers in giant cell arteritis (GCA), as C-reactive protein (CRP) may be unreliable in patients treated with Tocilizumab…”
    Get full text
    Journal Article
  2. 2

    Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014 by Schönermarck, Ulf, Csernok, Elena, Gross, Wolfgang L

    Published in Nephrology, dialysis, transplantation (01-04-2015)
    “…Anti-neutrophil cytoplasmic autoantibodies (ANCA) with specificity for proteinase 3 (PR3-ANCA) or myeloperoxidase (MPO-ANCA) are a defining feature of…”
    Get full text
    Journal Article
  3. 3

    Proinflammatory Cytokines and Autoimmunity in Churg-Strauss Syndrome by HELLMICH, B., CSERNOK, E., GROSS, W. L.

    Published in Annals of the New York Academy of Sciences (01-06-2005)
    “…: Churg‐Strauss syndrome (CSS) belongs to the antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitides and is further characterized by severe…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Eotaxin-3 is involved in Churg–Strauss syndrome – a serum marker closely correlating with disease activity by Polzer, K., Karonitsch, T., Neumann, T., Eger, G., Haberler, C., Soleiman, A., Hellmich, B., Csernok, E., Distler, J., Manger, B., Redlich, K., Schett, G., Zwerina, J.

    Published in Rheumatology (Oxford, England) (01-06-2008)
    “…Objective. Churg–Strauss Syndrome (CSS) is characterized by excessive eosinophil accumulation in peripheral blood and affected tissues with development of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's) by Henes, F O, Chen, Y, Bley, T A, Fabel, M, Both, M, Herrmann, K, Csernok, E, Gross, W L, Moosig, F

    Published in Annals of the rheumatic diseases (01-11-2011)
    “…To investigate the correlation of serum levels of high mobility group box 1 (HMGB1) with the extent of granulomatous inflammation in granulomatosis with…”
    Get more information
    Journal Article
  8. 8

    A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis by Csernok, E., Ahlquist, D., Ullrich, S., Gross, W. L.

    Published in Rheumatology (Oxford, England) (01-11-2002)
    “…Objective. To evaluate the performance of 11 commercial enzyme‐linked immunosorbent assay (ELISA) kits for the detection of antineutrophil cytoplasmic…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity by Herrmann, K, Schinke, S, Csernok, E, Moosig, F, Holle, J U

    Published in The open rheumatology journal (2015)
    “…Procalcitonin (PCT) is considered to be a specific marker for severe bacterial infections and sepsis. Elevated PCT levels have been reported in active…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3 by HELLMICH, B, CSEMOK, E, FREDENHAGEN, G, GROSS, W. L

    “…Conventional direct enzyme-linked immunosorbent assays (ELISA) for the detection of anti-neutrophil cytoplasm antibodies (ANCA) often lack sensitivity because…”
    Get full text
    Journal Article
  15. 15

    CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis by Lamprecht, P, Moosig, F, Csernok, E, Seitzer, U, Schnabel, A, Mueller, A, Gross, W L

    Published in Thorax (01-10-2001)
    “…BACKGROUND Lack of CD28 expression on peripheral blood CD4+ and CD8+ T cells has been reported in patients with Wegener's granulomatosis (WG), suggesting a…”
    Get full text
    Journal Article
  16. 16

    Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS) by Lamprecht, P, Moosig, F, Adam-Klages, S, Mrowietz, U, Csernok, E, Kirrstetter, M, Ahmadi-Simab, K, Schroder, J O, Gross, W L

    Published in Annals of the rheumatic diseases (01-11-2004)
    “…Case reports: A 66 year old female patient had relapsing fever and non-suppurative panniculitis suggestive of enigmatic “Weber-Christian disease” (WCD)…”
    Get full text
    Journal Article
  17. 17

    Evaluation of the FIDIS Vasculitis Multiplex Immunoassay for Diagnosis and Follow-up of ANCA-Associated Vasculitis and Goodpasture's Disease by DAMOISEAUX, J., VAESSEN, M., KNAPEN, Y., CSERNOK, E., STEGEMAN, C. A., VAN PAASSEN, P., COHEN TERVAERT, J. W.

    Published in Annals of the New York Academy of Sciences (01-08-2007)
    “…:  We have evaluated a new‐multiplex immunoassay (FIDIS Vasculitis) for simultaneous detection and quantification of anti‐MPO, ‐PR3, and ‐glomerular basement…”
    Get full text
    Journal Article
  18. 18

    Proteinase 3, protease-activated receptor-2 and interleukin-32 : linking innate and autoimmunity in Wegener's granulomatosis by CSERNOK, E, HOLLE, J. U, GROSS, W. L

    Published in Clinical and experimental rheumatology (01-05-2008)
    “…Proteinase 3 (PR3) is a multifunctional neutrophil-derived serine protease influencing cell cycle, differentiation, and cell death. This molecule is the main…”
    Get full text
    Journal Article
  19. 19

    Paradigm shift in ANCA diagnostics : New international consensus recommendations by Csernok, E, Kempiners, N, Hellmich, B

    Published in Zeitschrift für Rheumatologie (01-03-2017)
    “…Up to now indirect immunofluorescence (IIF) followed by an antigen-specific assay specific for proteinase 3 (PR3) or myeloperoxidase (MPO) has been the…”
    Get full text
    Journal Article
  20. 20

    Prevalence and spectrum of rheumatic diseases associated with proteinase 3‐antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase‐ANCA by Schönermarck, U., Lamprecht, P., Csernok, E., Gross, W. L.

    Published in Rheumatology (Oxford, England) (01-02-2001)
    “…Objectives. To evaluate the prevalence and association of antineutrophil cytoplasmic antibodies (ANCA) and their subtypes [proteinase 3 (PR3)‐ANCA,…”
    Get full text
    Journal Article